| Alyssa Marie Travalent, | |
|
4000 Cambridge St, Kansas City, KS 66160-8501 | |
| (417) 269-6000 | |
| Not Available |
| Full Name | Alyssa Marie Travalent |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 4000 Cambridge St, Kansas City, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134854581 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1-120852 (Kansas) | Secondary |
| 183500000X | Pharmacist | 2022027790 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alyssa Marie Travalent, 4000 Cambridge St, Kansas City, KS 66160-8501 Ph: () - | Alyssa Marie Travalent, 4000 Cambridge St, Kansas City, KS 66160-8501 Ph: (417) 269-6000 |
News Archive
One company's program to improve employee well-being led to improvements in worker health and productivity while decreasing health care costs, reports a case study in the October Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine.
With President Obama's recent State of the Union speech addressing the launch of a national precision medicine initiative to further tackle cancer and other diseases, a leading immunotherapy expert from Rutgers Cancer Institute of New Jersey weighs in on where we stand with precision immunology and personalized medicine and what needs to be accomplished.
PipelineRx, a leading clinical telepharmacy platform company supporting medication management, today announced continuing support from the California HealthCare Foundation to help improve quality of care by expanding ways pharmacists can be accessible to more patients in the acute setting.
In what is believed to be the biggest study of chronic fatigue syndrome (CFS) - also known as myalgic encephalomyelitis (ME) - in children to date, researchers at the University of Bristol (UK), have found that almost 2 per cent of 16-year-olds have CFS lasting more than six months and nearly 3 per cent have CFS lasting more than three months (the UK definition).
Two new studies revealed that anti-PD-1 immunotherapy given before surgery was safe and effective for patients with oral-cavity squamous cell carcinoma (OCSCC) and identified potential molecular biomarkers in the blood and tumors of patients that would show how likely it is that someone would respond to immunotherapy.
› Verified 5 days ago
Dr. Michael Craig Fink, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10200 Abilities Way, Kansas City, KS 66111 Phone: 913-304-3409 | |
Dr. Jeffrey Spiegel, PHARMD., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7836 State Ave, Kansas City, KS 66112 Phone: 913-299-6016 Fax: 913-299-1735 | |
Hannah Jeong, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 950 Minnesota Ave, Kansas City, KS 66101 Phone: 913-321-4505 | |
Dr. Thomas Mason Williams, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2850 State Ave, Kansas City, KS 66102 Phone: 913-621-7073 | |
Mr. Robert Keith Fullmer, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2300 Metropolitan Ave, Kansas City, KS 66106 Phone: 913-748-0502 Fax: 913-748-0503 | |
Molly Deann Holsworth, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 950 Minnesota Ave, Kansas City, KS 66101 Phone: 913-321-4505 | |
Susan Just, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4645 Shawnee Dr, Kansas City, KS 66106 Phone: 913-236-4000 |